A price cap on insulin from one of the three major manufacturers took effect on New Year's Day, giving more Americans with diabetes more affordable treatments. As of Jan. 1, 2024, Sanofi cut the ...

Eli Lilly says it will cut the list price of its nonbranded insulin to $25 a vial as of May 1, making it the lowest list-priced mealtime insulin available. Its current list price is $82.41 for a vial.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Insulin has come to embody the perversity of the U.S. health care system as list prices for the century-old drug, which 8.4 million Americans depend on for survival, quintupled over two decades to ...

This story has been updated. After years of rising insulin prices, the world’s three dominant makers of the diabetes treatment all announced sweeping price cuts in less than three weeks.

The Inflation Reduction Act places a $35 monthly cap on insulin prices for Medicare patients, providing relief for the 3.3 million beneficiaries who use some form of insulin, according to the ...

The Nevada Senate passed key bills put forward by Speaker Steve Yeager, including one that would cap the cost of insulin at ...

People with diabetes may use insulin pens, wearable pump devices, or a glass vial and syringe to deliver this needed medication. Costs vary depending on which method you choose. The price of ...

For years, that meant that every time a company raised a drug’s list price above inflation, community clinics paid less for it. Many drugs, including insulin, essentially became free.

Bucks County on Friday filed a lawsuit against several major pharmacy benefit managers (PBMs) and insulin manufacturers, contending that these healthcare giants have for decades colluded to unfairly ...

An estimated one in six Americans on insulin have rationed it due to cost, which can lead to death. Mutual Aid Diabetes, or MAD, is entirely volunteer-run. It came to fruition earlier in the Covid ...